Topics:

HER-2 Predicts Complete Pathologic Response to Chemo Neoadjuvant Chemotherapy

HER-2 Predicts Complete Pathologic Response to Chemo Neoadjuvant Chemotherapy

Optimal Care for HER2+ Breast Cancer

An interactive case challenge activity.

The goal of this activity is to clarify challenging treatment issues of HER2+ breast cancer including incorporation of predictive and prognostic biomarker tests and evidence-based data into practice when determining individualized strategies that improve patient survival and quality of life.Go to Activity

 
Loading comments...
Please Wait 20 seconds or click here to close